Ibogaine and the Treatment of Opioid Dependence

Record summary

Ibogaine research connects Bwiti ceremonial use of iboga in Central Africa with contemporary treatment claims for opioid dependence and reports of intense autobiographical or visionary experiences. Since 2010, observational studies, safety reviews and clinical discussions have assessed withdrawal outcomes, cardiovascular risks and the difficulty of separating pharmacology from ritual framing. The lead is useful for comparing culturally embedded initiation practices with medicalized underground treatment. Evidence remains preliminary, and reported efficacy must be distinguished from compelling subjective narratives.